Showing results (1-10 of 152) with videos related to
Sort By:
Pageof 16
Seminars in Immunology|November 15, 2021
Targeting GM-CSF in inflammatory and autoimmune disordersAdrian A Achuthan, Kevin M C Lee, John A HamiltonImmunotargets and Therapy|November 5, 2020
GM-CSF: A Promising Target in Inflammation and AutoimmunityKevin M C Lee, Adrian A Achuthan, John A HamiltonImmunology and Cell Biology|March 28, 2023
CCL17/TARC in autoimmunity and inflammation-not just a T-cell chemokineTanya J Lupancu, Mahtab Eivazitork, John A Hamilton, et al.Osteoarthritis and Cartilage|June 6, 2024
IL-23p19 in osteoarthritic pain and diseaseKevin M-C Lee, Tanya Lupancu, Adrian A Achuthan, et al.Scientific Reports|July 23, 2025
Screening of the FDA-approved drug library identifies CCL17 inhibitors that block arthritic painMahtab Eivazitork, Tanya J Lupancu, Keith Lim, et al.Frontiers in Immunology|July 17, 2023
Targeting transcription factors for therapeutic benefit in rheumatoid arthritisThivya Balendran, Keith Lim, John A Hamilton, et al.Cellular Signalling|April 22, 2026
CCL17 drives the expression of MMP9 and MMP13 expression via ERK1/2 and NF-κB signaling pathways in rheumatoid arthritisThivya Balendran, Tetiana Hourani, Subothini Ganeshalingam, et al.Arthritis Research & Therapy|April 26, 2022
The role of interleukin (IL)-23 in regulating pain in arthritisKevin M-C Lee, Jonathan P Sherlock, John A HamiltonIscience|October 20, 2023
Epigenetic and transcriptional regulation of CCL17 production by glucocorticoids in arthritisTanya J Lupancu, Kevin M C Lee, Mahtab Eivazitork, et al.Nature Reviews. Immunology|June 25, 2020
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approachesFrederick M Lang, Kevin M-C Lee, John R Teijaro, et al.Pageof 16